ICER Value Framework 2020 Update: Recommendations on the Aggregation of Benefits and Contextual Considerations

Angelis, 2018, Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries, Eur J Health Econ, 19, 123, 10.1007/s10198-017-0871-0 Clement, 2009, Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada, JAMA, 302, 1437, 10.1001/jama.2009.1409 Nicod, 2012, Commonalities and differences in HTA outcomes: a comparative analysis of five countries and implications for coverage decisions, Health Policy, 108, 167, 10.1016/j.healthpol.2012.09.012 Daniels, 1998, The ethics of accountability in managed care reform, Health Affairs, 17, 50, 10.1377/hlthaff.17.5.50 Daniels, 1999, Decisions about access to health care and accountability for reasonableness, J Urban Health, 76, 176 Garber, 1997, Economic foundations of cost-effectiveness analysis, J Health Econ, 16, 1, 10.1016/S0167-6296(96)00506-1 Pliskin, 1980, Utility functions for life years and health status, Oper Res, 28, 206, 10.1287/opre.28.1.206 Lakdawalla, 2018, Defining elements of value in health care—a health economics approach: an ISPOR Special Task Force Report [3], Value Health, 21, 131, 10.1016/j.jval.2017.12.007 2013 2014 2017 Persson, 2010, A case study of ex ante , value- based price and reimbursement decision- making: TLV and rimonabant in Sweden, Eur J Health Econ, 11, 195, 10.1007/s10198-009-0166-1 Golan, 2011, Health technology prioritization: Which criteria for prioritizing new technologies and what are their relative weights?, Health Policy, 102, 126, 10.1016/j.healthpol.2010.10.012 Devlin, 2011 Thokala, 2012, Multiple criteria decision analysis for health technology assessment, Value Health, 15, 1172, 10.1016/j.jval.2012.06.015 Kanavos, 2013 Marsh, 2014, Assessing the value of healthcare interventions using multi-criteria decision analysis: a review of the literature, Pharmacoeconomics, 32, 345, 10.1007/s40273-014-0135-0 Angelis, 2017, Multiple criteria decision analysis (MCDA) for evaluating new medicines in health technology assessment and beyond: the advance value framework, Soc Sci Med, 188, 137, 10.1016/j.socscimed.2017.06.024 Thokala, 2016, Multiple criteria decision analysis for health care decision making--an introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force, Value Health, 19, 1, 10.1016/j.jval.2015.12.003 Marsh, 2016, Multiple criteria decision analysis for health care decision making-Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force, Value Health, 19, 125, 10.1016/j.jval.2015.12.016 Radaelli, 2014, Implementation of EUnetHTA core Model® in Lombardia: the VTS framework, Int J Technol Assess Health Care, 30, 105, 10.1017/S0266462313000639 Tony, 2011, Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada, BMC Health Services Research, 11, 329, 10.1186/1472-6963-11-329 Jaramillo, 2016, Testing multi-criteria decision analysis for more transparent resource-allocation decision making in Colombia, Int J Technol Assess Health Care, 32, 307, 10.1017/S0266462316000350 Angelis, 2018, 3 Angelis, 2020, Multiple criteria decision analysis for HTA across four EU member states: piloting the Advance Value Framework, Soc Sci Med, 246, 10.1016/j.socscimed.2019.112595 Raiffa, 1968 Angelis, 2020, Advancing structured decision-making in drug regulation at the FDA and EMA, Br J Clin Pharmacol, 1 Keeney, 1976 Ralph, 1974, Multiplicative utility functions, Oper Res, 22, 22, 10.1287/opre.22.1.22 Angelis, 2016, Value-based assessment of new medical technologies: towards a robust methodological framework for the application of multiple criteria decision analysis in the context of health technology assessment, Pharmacoeconomics, 34, 435, 10.1007/s40273-015-0370-z Dawes, 1988 Miller, 1956, The magical number seven, plus or minus two: some limits on our capacity for processing information, Psychol Rev, 63, 81, 10.1037/h0043158 Thaler, 2008 Kahneman, 2011 Montibeller, 2015, Cognitive and motivational biases in decision and risk analysis, Risk Anal, 35, 1230, 10.1111/risa.12360 Nutt, 2010, Drug harms in the UK: a multicriteria decision analysis, Lancet, 376, 1558, 10.1016/S0140-6736(10)61462-6 Angelis, 2017, Multiple criteria decision analysis in the context of health technology assessment: a simulation exercise on metastatic colorectal cancer with multiple stakeholders in the English setting, BMC Med Inform Decis Mak, 17, 10.1186/s12911-017-0524-3 Felli, 2009, A multiattribute model for evaluating the benefit-risk profiles of treatment alternatives, Med Decis Mak, 29, 104, 10.1177/0272989X08323299 Marsh, 2017, Evaluation of COPD treatments: a multicriteria decision analysis of aclidinium and tiotropium in the United States, Value Health, 20, 132, 10.1016/j.jval.2016.08.724 Moore, 2017, Use of multicriteria decision analysis for assessing the benefit and risk of over-the-counter analgesics, J Pharm Pharmacol, 69, 10.1111/jphp.12770 Nixon, 2016, A case study using the PrOACT-URL and BRAT frameworks for structured benefit risk assessment, Biom J, 58, 8, 10.1002/bimj.201300248 Keeney, 1994, Managing nuclear waste from power plants, Risk Analysis, 14, 107, 10.1111/j.1539-6924.1994.tb00033.x Phillips, 2011, The Royal Navy's type 45 story: a case study Gregory, 2000, Using Stakeholder Values to Make Smarter Environmental Decisions, Environment, 42, 34 Bana e Costa, 2003, Multicriteria evaluation of flood control measures: the case of Ribeira do Livramento, Water Res Mgmt, 18, 263, 10.1023/B:WARM.0000043163.19531.6a French, 1992, Decision conferencing and the international Chernobyl project, J Radiolog Protection, 12, 17, 10.1088/0952-4746/12/1/003 2020 Morton, 2017, Treacle and smallpox: two tests for multicriteria decision analysis models in health technology assessment, Value Health, 20, 512, 10.1016/j.jval.2016.10.005 Marsh, 2018, The Use of MCDA in HTA: great potential, but more effort needed, Value Health, 21, 394, 10.1016/j.jval.2017.10.001 Marsh, 2018, Incorporating MCDA into HTA: challenges and potential solutions, with a focus on lower income settings, Cost Eff Res Alloc, 16, 43, 10.1186/s12962-018-0125-8 Phillips, 2017, Best Practice for MCDA in healthcare Oliveira, 2019, Multi-criteria decision analysis for health technology assessment: addressing methodological challenges to improve the state of the art, Eur J Health Econ, 1 2011 van Amsterdam, 2015, European rating of drug harms, J Psychopharm, 29, 655, 10.1177/0269881115581980 Angelis A, Thursz M, Ratziu V, et al. Early health technology assessment during nonalcoholic steatohepatitis drug development: a two-round, cross-country, multicriteria decision analysis. Medical Decision Making 940672. (In Press) Keeney, 1992 Phillips, 2007, Transparent prioritisation, budgeting and resource allocation with multi-criteria decision analysis and decision conferencing, Ann Op Res, 154, 51, 10.1007/s10479-007-0183-3 Claxton, 2015, Methods for the estimation of the National Institute for Health and care excellence cost-effectiveness threshold, Health Tech Assess, 19, 1, 10.3310/hta19140 Phillips, 1999, Group elicitation of probability distributions: are many heads better than one? Reagan-Cirincione, 1994, Improving the accuracy of group judgment: a process intervention combining group facilitation, social judgment analysis, and information technology, Org Behav Human Decis Proc, 58, 246, 10.1006/obhd.1994.1036 Montibeller, 2017, Individual and group biases in value and uncertainty judgments Kerr, 1996, Bias in judgment: comparing individuals and groups, Psych Rev, 103, 687, 10.1037/0033-295X.103.4.687 2020 Meehl, 1954 Montibeller, 2020, A critical analysis of multi-criteria models for the prioritisation of health threats, Eur J Oper Res, 281, 87, 10.1016/j.ejor.2019.08.018 Phelps, 2018, Approaches to aggregation and decision making—a health economics approach: an ISPOR Special Task Force Report [5], Value Health, 21, 146, 10.1016/j.jval.2017.12.010 HM Phillips, 1984, A theory of requisite decision models, Acta Psych, 56, 29, 10.1016/0001-6918(84)90005-2 Phillips, 1993, Faciliated work groups: theory and practice, The J Operation Res Soc, 44, 10.1057/jors.1993.96 Dodgson, 2000 Phillips, 2007, Decision conferencing Phelps, 2018, Resource allocation in decision support frameworks, Cost Eff Resourc Alloc, 16 Salo, 2011 2018